# Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients

> **NCT05897840** · NA · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 100 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DEVICE:** Fiber-optic probe CeVOX

## Key facts

- **NCT ID:** NCT05897840
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-04
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05897840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05897840, "Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05897840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*